Company intelligence / Profile preview

Grzybowski Scientific Inventions

Ulsan, South Korea

Ownership: Private
Development stage: Other

Overview

Grzybowski Scientific Inventions developed Chematica, a computer-aided retro-synthesis software that uses advanced reaction rules and proprietary algorithms to identify optimal chemical synthesis pathways. The tool was recognized as the first computer program capable of 'chemical thinking' and the only expert system able to design chemically viable synthetic pathways for complex targets including drugs, natural products, and theoretical molecules within seconds.

Modalities: Software platform for chemical synthesis planning
Industry: Drug Discovery Services

Partnerships

Merck KGaA/MilliporeSigma

Beyond the preview

Go deeper on Grzybowski Scientific Inventions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Grzybowski Scientific Inventions.

Explore the full profile